ReVision Optics, Inc. Company Profile
ReVision Optics, Inc. focuses on the research and development of custom optical solutions dedicated to vision correction. RVO’s first product is the PresbyLens* inlay, a unique patented refractive surgery solution. This inlay is designed to improve the near vision that has been lost by the eye’s natural aging process called presbyopia. The PresbyLens inlay is removable, and provides an ideally suited surgical option for near and intermediate vision enhancement.
News Articles
Series F brings in $15mm for [ReVision Optics]
[ReVision Optics Inc.] (corneal implant to improve vision) has raised $15mm through what is believed to be its Series F venture round. There were eight undisclosed investors.
Leading Photonics and Laser Researchers to Present Latest Work at SPIE Optics + Optoelectronics
CARDIFF, UK (PRWEB) March 20, 2013 More than 600 technical papers on the latest developments in optics and optoelectronic devices, technologies, and their integration will be presented at SPIE Opt...
Spider silk’s hidden talents may produce eco-friendly optics
At this week’s Frontiers in Optics 2012, physicists are presenting possible applications based on research that uses natural spider silk to catch light. Recent findings could present an eco-friendl...
San Francisco, CA (PRWEB) April 18, 2013 TrueVision® 3D Surgical and i-Optics® announced today a collaboration designed to integrate the precision measurements of the i-Optics Cassini...
Corneal inlay enters phase III trial for presbyopia
A proprietary clear corneal inlay (PresbyLens, ReVision Optics Inc. [RVO]) has entered the final phase of its U.S. clinical trial under an investigational device exemption.
Optics: Nanorod shades soak up the rays
An array of nanorods can reflect nearly all light over a precise set of wavelengths, making this a promising material for filters and other optics applications.Stéphane Collin at the Laboratory of Ph...
ReVision Optics Introduces Raindrop as Worldwide Brand for Its Inlay to Treat Presbyopia
ReVision Optics®, Inc. (RVO), a leader in implantable inlay technology to treat presbyopia, introduces the Raindrop™ Near Vision Inlay as the new worldwide brand for its...
ReVision Optics®, Inc. (RVO), the leader in implantable inlay technology to treat presbyopia, has received conditional approval from the U.S. Food and Drug Administration...
Drugs and Medications
Minidrops [Optics Laboratory, Inc]
Occufresh [Optics Laboratory, Inc]
Tinted moisturizer spf 45 matte [Goodier Cosmetics LP]
PubMed Articles
BACKGROUND: The published data on pain and physical function before and after revision of total hip arthroplasty (THA) is scarce. The study reports the course and interrelationships of radiographic lo...
Failure following revision total knee arthroplasty: infection is the major cause.
The objective of this study was to evaluate the survivorship of revision TKA and determine the reasons and predictors for failure. Between January 1999 to December 2005, 499 total knee arthroplasty re...
What Are the Causes of Revision Total Knee Arthroplasty in Japan?
BACKGROUND: There is limited information regarding the cause of revision TKA in Asia, especially Japan. Owing to differences in patient backgrounds and lifestyles, the modes of TKA failures in Asia ma...
Large-aperture focusing of x rays with micropore optics using dry etching of silicon wafers.
Large-aperture focusing of Al Kα 1.49 keV x-ray photons using micropore optics made from a dry-etched 4 in. (100 mm) silicon wafer is demonstrated. Sidewalls of the micropores are smoothed with hig...
We identified 128 revision total hip arthroplasties from 1993 to 2005 involving a well-fixed Harris-Galante Porous (HGP)-I or HGP-II acetabular component with minimum 2-year post-revision follow-up. T...
Clinical Trials
Cementless One-stage Revision of the Chronic Infected Hip Arthroplasty
The investigators hypothesise that cementless one-stage exchange revision surgery can be performed in patients with chronically infected hip replacement with substantial benefits for the p...
Early Clinical Results of Mobile-Bearing Revision Total Knee Arthroplasty
Long term follow-up is needed to determine whether current Mobile Bearing revision Total Knee Arthroplasty (TKA) designs will improve implant longevity. The potential advantages of mobile...
Bisphosphonates and Impaction Grafting in Hip Revision
The primary focus of this study is to investigate whether increased bone density of the graft in revision arthroplasty of the hip can cause a decreased micromotion of the implant relative...
Restoration® Modular Revision Hip System Post Market Study
The purpose of this study is to demonstrate survivorship of the femoral stem at 5 years.
Impact of Pocket Revision on Infection Rates
To determine the effect of scar tissue removal on the rate of infection and any other complications such as bleeding in patients with an ICD or pacemaker who have the device generator or l...
Companies
ReVision Optics, Inc. focuses on the research and development of custom optical solutions dedicated to vision correction. RVO’s first product is the PresbyLens* inlay, a uniq...
ReVision Therapeutics Inc. is an ophthalmic biopharmaceutical company developing a novel small molecule drug for the treatment and prevention of the dry form of age-related macular degeneration (AMD)....
Edmund Optics and its parent company Edmund Optics Inc. (EO) have been leading suppliers of optics and optical components to industry since 1942, designing and manufacturing a wide array of multi-elem...
Chinese Optics Letters is one of the leading journals for optics in China. Published in English, it promotes the generation, application, and archiving of knowledge in all fields...
Net Optics is the global leader of intelligent network access solutions, helping more than 6,300 enterprises, service providers and government organizations improve network perfor...
More Information about "ReVision Optics, Inc." on BioPortfolio
We have published hundreds of ReVision Optics, Inc. news stories on BioPortfolio along with dozens of ReVision Optics, Inc. Clinical Trials and PubMed Articles about ReVision Optics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ReVision Optics, Inc. Companies in our database. You can also find out about relevant ReVision Optics, Inc. Drugs and Medications on this site too.
